Sugi Predict

Sugi Predict / Compounds / SCHEMBL16449748

SCHEMBL16449748

SCHEMBL16449748

CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@]3(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O3)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCCCCCCC

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ SIGLEC7 Q9Y286 6/20 0.59
▸ SELP P16109 8/20 0.54
▸ MAG P20916 5/20 0.52
▸ SELL P14151 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29361662 1.00 SIGLEC7 (0.59) SIGLEC7SELPMAGSELL
SCHEMBL30739464 1.00 SIGLEC7 (0.59) SIGLEC7SELPMAGSELL
SCHEMBL30173253 1.00 SIGLEC7 (0.59) SIGLEC7SELPMAGSELL
SCHEMBL29600828 1.00 SIGLEC7 (0.59) SIGLEC7SELPMAGSELL
SCHEMBL30651675 1.00 SIGLEC7 (0.59) SIGLEC7SELPMAGSELL
SCHEMBL30712647 1.00 SIGLEC7 (0.59) SIGLEC7SELPMAGSELL
SCHEMBL30913852 1.00 SIGLEC7 (0.59) SIGLEC7SELPMAGSELL
SCHEMBL29538893 1.00 SIGLEC7 (0.59) SIGLEC7SELPMAGSELL
SCHEMBL30650429 1.00 SIGLEC7 (0.59) SIGLEC7SELPMAGSELL
SCHEMBL30739475 1.00 SIGLEC7 (0.59) SIGLEC7SELPMAGSELL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240385201-A1 LIPIDOMIC BIOMARKERS FOR ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE ZORA BIOSCIENCES OY (FI) 2024-11-21 — — US disclosed
US-12025623-B2 Lipidomic biomarkers for atherosclerosis and cardiovascular disease ZORA BIOSCIENCES OY (FI) 2024-07-02 — — US disclosed
US-9340814-B2 Method for producing a recombinant protein using a cell line adapted to a protein-free and lipid-free medium KYOKUTO PHARMACEUTICAL INDUSTRIAL CO., LTD. (JP) 2016-05-17 — — US disclosed
US-20150044719-A1 METHOD FOR PRODUCING A RECOMBINANT PROTEIN USING A CELL LINE ADAPTED TO A PROTEIN-FREE AND LIPID-FREE MEDIUM NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) 2015-02-12 — — US disclosed
US-20150044769-A1 CELL LINE ADAPTED TO A PROTEIN-FREE AND LIPID-FREE MEDIUM, A METHOD FOR PRODUCING THE CELL LINE, AND A MEDIUM FOR THE CELL LINE KYOKUTO PHARMACEUTICAL INDUSTRIAL CO., LTD. (JP) 2015-02-12 — — US disclosed
Send feedback